HIDRALAZINA Y ALFAMETILDOPA PDF

Global and regional estimates of preeclampsia and eclampsia: a systematic review. The burden of eclampsia: results from a multicenter study on surveillance of severe maternal morbidity in Brazil. PLoS One. Hypertensive disorders in pregnancy: frequency and associated factors in a cohort of Brazilian women.

Author:Shakatilar Dotaur
Country:Lesotho
Language:English (Spanish)
Genre:Travel
Published (Last):13 October 2015
Pages:146
PDF File Size:17.8 Mb
ePub File Size:8.99 Mb
ISBN:816-8-45226-484-4
Downloads:13646
Price:Free* [*Free Regsitration Required]
Uploader:Kagakasa



Global and regional estimates of preeclampsia and eclampsia: a systematic review. The burden of eclampsia: results from a multicenter study on surveillance of severe maternal morbidity in Brazil. PLoS One. Hypertensive disorders in pregnancy: frequency and associated factors in a cohort of Brazilian women.

Hypertens Pregnancy. Maternal mortality in Brazil and proportion to hypertensive disorders: a trend of stagnation. Pregnancy Hypertens.

Hypertension in pregnancy. Obstet Gynecol. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. Antiplatelet agents for preventing pre-eclampsia and its complications. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.

Committee on Obstetric Practice. Committee Opinion No. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: Erratum in: BJOG. Bed rest with or without hospitalisation for hypertension during pregnancy. Antenatal day care units versus hospital admission for women with complicated pregnancy.

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation HYPITAT : a multicentre, open-label randomised controlled trial. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation HYPITAT-II : an open-label, randomised controlled trial.

Erratum in: Lancet. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health. Does sodium nitroprusside kill babies? A systematic review. Sao Paulo Med J. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.

Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. Drugs for treatment of very high blood pressure during pregnancy.

Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada and Israel, Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomized control trial.

Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Brasilia; Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials.

Medicines and breastfeeding: update and revision applied to mother and baby care. Rev Paul Pediatr. Arq Bras Cardiol. Erratum in: Arq Bras Cardiol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Vasodilatadores: hidralazina e minoxidil. BCC: verapamil, nifedipino, nimodipino e nitrendipino. IECA: benazepril, captopril e enalapril. Seguros DIU: indapamida, furosemida e triantereno. BCC: anlodipino, isradipino, nisoldipino.

IECA: lisinopril, ramipril. BRA: candesartana e olmesartana. Potencialmente perigosos. Como citar este artigo. DIU: hidroclorotiazida e espironolactona. DIU: indapamida, furosemida e triantereno.

CAVALEIROS DA TAVOLA REDONDA PDF

05_HIPERTENSAO_ARTERIAL

Vasodilatadores: hidralazina e minoxidil. BCC: verapamil, nifedipino, nimodipino e nitrendipino. IECA: benazepril, captopril e enalapril. Seguros DIU: indapamida, furosemida e triantereno. BCC: anlodipino, isradipino, nisoldipino. IECA: lisinopril, ramipril. BRA: candesartana e olmesartana.

LOST IN THE FUNHOUSE BARTH PDF

404 Page Not Found

.

Related Articles